Intensive Chemotherapy vs. Hypomethylating Agents in Older Adults with Newly Diagnosed High-Risk Acute Myeloid Leukemia: A Single Center Experience

被引：1
|
作者：
Vachhani, Pankit [1 ]
Al Yacoub, Raed [2 ]
Miller, Austin [3 ]
Cronin, Tara [1 ]
Ontiveros, Evelena [1 ,4 ]
Thompson, James [1 ,4 ]
Griffiths, Elizabeth [1 ,4 ]
Wang, Eunice [1 ,4 ]
机构：
[1] Roswell Park Canc Inst, Dept Med, Buffalo, NY 14263 USA
[2] Jacobs Sch Med & Biomed Sci, Dept Med, Buffalo, NY USA
[3] Roswell Park Canc Inst, Dept Biostat & Bioinformat, Buffalo, NY 14263 USA
[4] Roswell Park Canc Inst, Dept Med, Leukemia Serv, Buffalo, NY 14263 USA
来源：
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA | 2017年 / 17卷
关键词：
D O I：
10.1016/j.clml.2017.07.075
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
AML-172
引用
收藏
页码：S288 / S289
页数：2
相关论文
共 50 条
  • [31] Outcomes of decitabine treatment for newly diagnosed acute myeloid leukemia in older adults
    Yoo, Kwai Han
    Cho, Jinhyun
    Han, Boram
    Kim, Se Hyung
    Shin, Dong-Yeop
    Hong, Junshik
    Kim, Hawk
    Kim, Hyo Jung
    Zang, Dae young
    Yoon, Sung-Soo
    Jin, Jong-Youl
    Lee, Jae Hoon
    Hong, Dae-Sik
    Park, Seong Kyu
    PLOS ONE, 2020, 15 (08):
  • [32] A Survival Analysis of Acute Myeloid Leukemia Patients Treated With Intensive Chemotherapy: A Single Center Experience
    Jimbu, Laura
    Valeanu, Madalina
    Adrian, Trifa
    Mesaros, Oana
    Bojan, Anca
    Dima, Delia
    Parvu, Andrada
    Rus, Ioana C.
    Tomuleasa, Ciprian
    Torok, Tunde
    Urian, Laura
    Vasilache, Anca
    Zdrenghea, Mihnea
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2023, 15 (08)
  • [33] Outpatient intensive induction chemotherapy for acute myeloid leukemia and high-risk myelodysplastic syndrome
    Mabrey, Frances Linzee
    Gardner, Kelda M.
    Dorcy, Kathleen Shannon
    Perdue, Andrea
    Smith, Heather A.
    Davis, Alicyn M.
    Hammer, Cody
    Rizzuto, Donelle
    Jones, Sunny
    Quach, Kim
    Scott, Bart L.
    Hendrie, Paul C.
    Percival, Mary-Elizabeth M.
    Walter, Roland B.
    Appelbaum, Frederick R.
    Estey, Elihu H.
    Becker, Pamela S.
    BLOOD ADVANCES, 2020, 4 (04) : 611 - 616
  • [34] Decitabine Versus Intensive Chemotherapy for Elderly Patients With Newly Diagnosed Acute Myeloid Leukemia
    Choi, Eun-Ji
    Lee, Je-Hwan
    Park, Han-Seung
    Lee, Jung-Hee
    Seol, Miee
    Lee, Young-Shin
    Kang, Young-Ah
    Jeon, Mijin
    Woo, Ji Min
    Lee, Kyoo-Hyung
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2019, 19 (05): : 290 - +
  • [35] Comparing the efficacy and safety of venetoclax combined with hypomethylating agents versus intensive chemotherapy as induction therapy in newly diagnosed core binding factor acute myeloid leukemia patients
    Shen, Jingyi
    Shan, Meng
    Chu, Mengqian
    Cai, Yiming
    Rui, Jingwen
    Chen, Suning
    Wu, Depei
    Xu, Yang
    BLOOD CANCER JOURNAL, 2025, 15 (01):
  • [36] Decitabine Versus Intensive Chemotherapy for Elderly Patients with Newly Diagnosed Acute Myeloid Leukemia
    Choi, Eun-Ji
    Lee, Je-Hwan
    Park, Han-Seung
    Lee, Jung-Hee
    Seol, Miee
    Lee, Young-Shin
    Kang, Young-Ah
    Jeon, Mijin
    Woo, Ji Min
    Lee, Kyoo Hyung
    BLOOD, 2018, 132
  • [37] Real-World Experience of Adults With Acute Myeloid Leukemia on Hypomethylating Agents With or Without Venetoclax at a Comprehensive Cancer Center
    Freeman, Tracelyn
    Williams, Kiersten
    Puto, Marcin
    Waller, Allyson
    McLaughlin, Eric M.
    Blachly, James S.
    Roddy, Julianna
    WORLD JOURNAL OF ONCOLOGY, 2023, 14 (01) : 40 - 50
  • [38] Early preemptive ICU admission for newly diagnosed high-risk acute myeloid leukemia patients
    Saillard, Colombe
    Elkaim, Elodie
    Rey, Jerome
    d'Incan, Evelyne
    Charbonnier, Aude
    Etienne, Anne
    Sannini, Antoine
    Chow-Chine, Laurent
    Bisbal, Magali
    Vey, Norbert
    Mokart, Djamel
    LEUKEMIA RESEARCH, 2018, 68 : 29 - 31
  • [39] FLAG-IDA Plus Venetoclax in High-Risk Newly Diagnosed and Relapsed or Refractory Acute Myeloid Leukemia: The Princess Margaret Cancer Center Experience
    Al-Shaibani, Eshrak
    Davidson, Marta Beata
    Bankar, Aniket
    Chan, Steven M.
    Sibai, Hassan
    Maze, Dawn C.
    Schimmer, Aaron
    Minden, Mark D.
    Yee, Karen
    Gupta, Vikas
    Schuh, Andre C.
    Richard-Carpentier, Guillaume
    BLOOD, 2024, 144 : 4274 - 4274
  • [40] Epigenetic therapy is associated with similar survival compared with intensive chemotherapy in older patients with newly diagnosed acute myeloid leukemia
    Quintas-Cardama, Alfonso
    Ravandi, Farhad
    Liu-Dumlao, Theresa
    Brandt, Mark
    Faderl, Stefan
    Pierce, Sherry
    Borthakur, Gautam
    Garcia-Manero, Guillermo
    Cortes, Jorge
    Kantarjian, Hagop
    BLOOD, 2012, 120 (24) : 4840 - 4845
12345